Articles dans des revues avec comité de lecture (257)
83.
Lamoral-Theys, D., Le Mercier, M., Le Calve, B., Rynkowski, M., Bruyère, C., Decaestecker, C., Haibe-Kains, B., Bontempi, G., Dubois, J., Lefranc, F., & Kiss, R. (2010). Long-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cells. Neoplasia (New York, N.Y.), 12(1), 69-79. doi:10.1593/neo.9136084.
Wauthoz, N., Deleuze, P., Hecq, J., Roland, I., Saussez, S., Adanja, I., Debeir, O., Decaestecker, C., Mathieu, V., Kiss, R., & Amighi, K. (2010). In vivo assessment of temozolomide local delivery for lung cancer inhalation therapy. European journal of pharmaceutical sciences, 39, 402-411. doi:10.1016/j.ejps.2010.01.01085.
Adanja, I., Debeir, O., Megalizzi, V., Kiss, R., Warzée, N., & Decaestecker, C. (2010). Automated tracking of unmarked cells migrating in three-dimensional matrices applied to anti-cancer drug screening. Experimental cell research, 316(2), 181-193. doi:10.1016/j.yexcr.2009.10.00486.
Cludts, S., Decaestecker, C., Mahillon, V., Chevalier, D., Kaltner, H., André, S., Remmelink, M., Leroy, X., Gabius, H.-J., & Saussez, S. (2009). Galectin-8 up-regulation during hypopharyngeal and laryngeal tumor progression and comparison with galectin-1, -3 and -7. Anticancer research, 29(12), 4933-4940.87.
Megalizzi, V., Decaestecker, C., Debeir, O., Spiegl-Kreinecker, S., Berger, W., Lefranc, F., Kast, R. E., & Kiss, R. (2009). Screening of anti-glioma effects induced by sigma-1 receptor ligands: potential new use for old anti-psychiatric medicines. European journal of cancer, 45(16), 2893-2905. doi:10.1016/j.ejca.2009.07.01188.
Leyman, S., Sidani, M., Ritsma, L., Waterschoot, D., Eddy, R., Dewitte, D., Debeir, O., Decaestecker, C., Vandekerckhove, J., van Rheenen, J., Ampe, C., Condeelis, J., & Van Troys, M. (2009). Unbalancing the phosphatidylinositol-4,5-bisphosphate-cofilin interaction impairs cell steering. Molecular biology of the cell, 20(21), 4509-4523. doi:10.1091/mbc.E09-02-012189.
Decaestecker, C., Moles Lopez, X., D'Haene, N., Roland, I., Guendouz, S., Duponchelle, C., Berton, A., Debeir, O., & Salmon, I. (2009). Requirements for the valid quantification of immunostains on tissue microarray materials using image analysis. Proteomics, 9(19), 4478-4494. doi:10.1002/pmic.20080093690.
Mathieu, A., Weynand, B., Verbeken, E., Da Silva, S., Decaestecker, C., Salmon, I., & Demetter, P. (2009). Comparison of four antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in non-small cell lung cancer. Lung cancer, 1301, 152-162. doi:10.1016/j.lungcan.2009.09.00391.
Capouillez, A., Debauve, G., Decaestecker, C., Filleul, O., Chevalier, D., Mortuaire, G., Coppée, F., Leroy, X., Belayew, A., & Saussez, S. (2009). The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas. Histopathology, 55(1), 77-90. doi:10.1111/j.1365-2559.2009.03330.x92.
Lefranc, F., Sauvage, S., Van Goietsenoven, G., Megalizzi, V., Lamoral-Theys, D., Debeir, O., Spiegl-Kreinecker, S., Berger, W., Mathieu, V., Decaestecker, C., & Kiss, R. (2009). Narciclasine, a plant growth modulator, activates Rho and stress fibers in glioblastoma cells. Molecular cancer therapeutics, 8(7), 1739-1750. doi:10.1158/1535-7163.MCT-08-093293.
Marechal, R., Demetter, P., Nagy, N., Berton, A., Decaestecker, C., Polus, M., Closset, J., Devière, J., Salmon, I., & Van Laethem, J.-L. (2009). High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. British Journal of Cancer, 100(9), 1444-1451. doi:10.1038/sj.bjc.660502094.
Le Mercier, M., Fortin, S., Mathieu, V., Roland, I., Spiegl-Kreinecker, S., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Berger, W., Lefranc, F., & Kiss, R. (2009). Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression. Neoplasia (New York, N.Y.), 11(5), 485-496.